CollabRx
Company

Last deal

$1.6M

Amount

Venture - Series Unknown

Stage

14.04.2011

Date

1

all rounds

$1.6M

Total amount

General

About Company
CollabRx leverages information technology to offer personalized cancer treatment planning services.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Tegal Corporation

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

By combining cutting-edge therapies with insights from leading cancer experts, CollabRx provides personalized cancer treatment planning tailored to the specific needs of patients with advanced cancers who have exhausted standard care options. Rennova Health Inc, on the other hand, is a vertically integrated healthcare company that offers a range of products and services. Its clinical laboratory operations segment specializes in urine and blood toxicology as well as pain medication testing for physicians, clinics, and rehabilitation facilities in the US. Additionally, Rennova Health Inc has acquired hospital assets, expanding its presence in the healthcare industry.
Contacts